75.00

Content Details
Information on this page was last modified on : 2021/05/08 2:37:00 PM

PENTAZOWAN 30mg Injection 1mlx5s

(1 customer review)

Pentazocine:30mg | Opioid analgesics

Manufactured / Marketed By : Swan Product Form : InjectionPack Size : 1mlx5sIngredients : Pentazocine:30mgGeneric Category : Opioid analgesics

How it works

PENTAZOWAN 30mg Injection 1mlx5s works by changing the way the brain and nervous system respond to pain.

Side effects

Major & minor side effects for PENTAZOWAN 30mg Injection 1mlx5s

  • Hypersensitivity rare
  • Drowsiness
  • Change in mood
  • Headache
  • Constipation
  • Nausea and vomiting
  • Allergic skin reaction
  • Respiratory depression rare
  • Trouble sleeping rare
  • Blurred vision rare

Uses of PENTAZOWAN 30mg Injection 1mlx5s

What is it prescribed for?

  • Anesthesia

    This medicine is used as preoperative or pre-anesthetic medication as well as a supplementation to surgical anesthesia to maintain the level of anesthetic effect.

  • Moderate to severe pain

    This medicine is used to relieve moderate to severe pain when the patient's pain is not adequately controlled by alternative analgesic medicines or the pain is severe enough to require the use of an opioid analgesic.

  • Labor pain

    This medicine is used to relieve the severe pain experienced by women during delivery of a baby.

Concerns

Frequently asked questions

  • Onset of action

    The effect of this medicine can be observed within 2 to 3 minutes of intravenous, 15 to 20 minutes of intramuscular and subcutaneous administration.

  • Duration of Effect

    The effect of this medicine lasts for an average duration of 3 hours.

  • Safe with Alchohol?

    Alcohol should not be consumed while receiving this medicine since it may increase the risk of drowsiness, lightheadedness, impairment in thinking and judgment, etc. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating heavy machinery if you consume alcohol during treatment with this medicine.

  • Is it habit forming?

    Habit forming tendency has been reported, especially after prolonged use. Patients should be monitored closely for any signs of abuse or addiction. Proper assessment of the patient, periodic reevaluation, and proper dispensing is recommended to limit the abuse of this medicine.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to PENTAZOWAN 30mg Injection 1mlx5s or any other inactive ingredients present along with it.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

General Warnings
  • Use in pediatrics

    This medicine is not recommended for use in patients less than 1 year of age since the safety and efficacy of use are not clinically established.

  • Respiratory depression

    This medicine may cause life-threatening respiratory depression. Close monitoring of respiratory function is recommended while using this medicine. Equipment for resuscitation should be immediately available if the injection form of this medicine is used.

  • Neonatal Opioid Withdrawal Syndrome

    This medicine may cause life-threatening withdrawal symptoms in neonates born to women who were under prolonged therapy with this medicine. Such neonates should be monitored closely for any unusual side effects. Appropriate corrective measures may be required based on the clinical condition.

  • Adrenal insufficiency

    This medicine may cause adrenal insufficiency like other opioid medicines, hence caution is advised while using this medicine for more than one month. Any unusual symptoms should be reported to the doctor on priority. Appropriate corrective measures, gradual withdrawal of therapy, and replacement with a suitable alternative may be required based on the clinical condition.

  • Severe hypotension

    This medicine may cause severe hypotension while getting up from a lying or a sitting position. Patients are advised to get up slowly from a sitting or a lying position to avoid sudden hypotension, fainting, dizziness, etc. Report any unusual symptoms to the doctor immediately. Close monitoring of blood pressure, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

  • Withdrawal symptoms

    Abrupt discontinuation of therapy may cause withdrawal symptoms, especially after prolonged use. Gradual tapering of dosage is recommended to avoid withdrawal symptoms.

  • Sports

    Use of this medicine is prohibited at all times according to category S7 of World Anti-Dopping Agency (WADA).

  • Driving or operating machinery

    Use of this medicine may cause drowsiness or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Dosage

  • Missed Dose

    Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low. Contact your doctor immediately for further instructions if you miss a scheduled dose of this medicine.

  • Overdose

    Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

Interactions

Interaction with Medicines
  • Baclofen severe
  • Citalopram severe
  • Ondansetron severe
  • Tramadol severe
  • Alprazolam severe
  • Fentanyl severe
  • Alvimopan severe
Disease interactions
  • severe

    Therapy with this medicine should be administered cautiously in patients with impaired gastrointestinal function due to the increased risk of constipation, elevated intraluminal pressure, and spasm. Patients should be monitored closely for any adverse effects. Replacement with a suitable alternative may be required based on the clinical condition.

  • severe

    Therapy with opioids should be avoided or has to be given cautiously in patients with infectious diarrhoea, particularly that due to pseudomembranous enterocolitis or enterotoxin-producing bacteria or if accompanied by high fever, pus, or blood in the stool. This medicine may prolong and/or worsen diarrhoea.

  • severe

    Therapy with opioids should be administered cautiously and initiated at reduced dosages in patients with liver diseases due to the increased risk of severe adverse effects. Subsequent doses should be titrated based on individual response rather than a fixed dosing schedule.

  • severe

    Therapy with opioids should be administered cautiously and initiated at reduced dosages in patients with kidney dysfunction due to the increased risk of severe adverse effects. Subsequent doses should be titrated based on individual response rather than a fixed dosing schedule.

  • severe

    Opioid analgesics should be administered cautiously and only if the benefit of using this medicine outweighs the risks in patients with coronary insufficiency or acute myocardial infarction.

  • severe

    Caution is advised while using this medicine in patients with a head injury, intracranial lesions, or pre-existing elevated CSF pressure due to the increased risk of cerebral hypoxia and vasodilation leading to increased intracranial pressure.

  • severe

    Therapy with opioids should be administered cautiously and initiated at reduced dosages in patients with severe CNS or respiratory depression due to the increased risk of worsening of the patient's condition. Close monitoring of pulmonary function is recommended for such patients. Equipment for resuscitation should be immediately available if required.

General Instructions

This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.

Other details

  • Usage does not depend on food timings
  • To be taken as instructed by doctor
  • Causes sleepiness

References

Additional Information:

One of the following licensed pharmacy from the nearest location will deliver PENTAZOWAN 30mg Injection 1mlx5s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

1 review for PENTAZOWAN 30mg Injection 1mlx5s

  1. Salman Ali

    Salman Ali submitted 5 stars.

Add a review
Shopping Cart